Hydromorphone Extended-Release Tablets and Mogamulizumab-kpkc Intravenous
Determining the interaction of Hydromorphone Extended-Release Tablets and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydromorphone
Brand name: Dilaudid, Exalgo, Hydrostat IR, Dilaudid-HP
Synonyms: Hydromorphone, HYDROmorphone
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydromorphone Extended-Release Tablets-Molindone
- Hydromorphone Extended-Release Tablets-Mometasone (Oral Inhalation)
- Hydromorphone Extended-Release Tablets-Mometasone and Formoterol
- Hydromorphone Extended-Release Tablets-Mometasone and formoterol Inhalation
- Hydromorphone Extended-Release Tablets-Mometasone Cream
- Hydromorphone Extended-Release Tablets-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Hydromorphone Hydrochloride
- Mogamulizumab-kpkc Intravenous-Hydromorphone injection
- Mogamulizumab-kpkc Intravenous-Hydromorphone Liquid
- Mogamulizumab-kpkc Intravenous-Hydromorphone rectal
- Mogamulizumab-kpkc Intravenous-Hydromorphone Suppository
- Mogamulizumab-kpkc Intravenous-Hydromorphone Tablets